Patent Assignment
Reel/Frame 075498/0899
Security Interest
Recorded: 2026-05-04
Pages: 72
Assignors
LEXICON PHARMACEUTICALS, INC.
Executed: 2026-05-04
LEXICON PHARMACEUTICALS (NEW JERSEY), INC.
Executed: 2026-05-04
LION ACQUISITION CORPORATION
Executed: 2026-05-04
Assignee
HERCULES CAPITAL, INC., AS AGENT
1 NORTH B STREET, SUITE 2000, SAN MATEO, CALIFORNIA, 94401
Covered Properties
(71)
Use of Sotagliflozin for the Treatment of Patients with Type 1 Diabetes Mellitus
Application:
18/613,381 →
Publication:
US US20240226125A1
Process for Preparing the Crystalline Form Ii of Sotagliflozin
Application:
17/631,209 →
Publication:
US US20220235085A1
Sotagliflozin for Improving Left Atrial Function
Application:
18/270,598 →
Publication:
US US20240100013A1
Methods and Compounds Useful in the Synthesis of an AAK1 Inhibitor
Application:
19/191,629 →
Publication:
US US20250282747A1
Solid Forms of (S)-1-((2',6-Bis(Difluoromethyl)-[2,4'-Bipyridin]-5-Yl)Oxy)-2,4-Dimethylpentan-2-Amine and Methods of Their Use
Application:
19/220,294 →
Publication:
US US20250346570A1
Compounds and Methods for Treating Spasticity
Methods of Treating Type 1 Diabetes and Kidney Disease
Application:
18/897,158 →
Publication:
US US20250108032A1
Methods of Reducing the Risk of Cardiovascular Events in Patients with Left Ventricular Hypertrophy
Application:
18/905,496 →
Publication:
US US20250114323A1
Methods and Compositions for the Treatment of Hepatic Encephalopathy
Application:
18/939,816 →
Publication:
US US20250170157A1
Compounds and Methods for Treating Chemotherapy-Induced Pain
Application:
19/053,009 →
Publication:
US US20250262197A1
Antibacterial Agents
Application:
19/037,815 →
Publication:
US US20250179008A1
Compounds and Methods of Their Use
Application:
19/052,650 →
Publication:
US US20250275959A1
Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
Piperdine-Based Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
Sulfanyl-Tetrahydropyran-Based Compounds and Methods of Their Use
Sodium Glucose Co-Transporter Inhibitors and Methods of Their Use
Multicyclic Compounds and Methods of Their Use
4-Piperidin-1-Yl-7H-Pyrrolo[2,3-D]Pyrimidine Compounds
Imidazole-Based Compounds, Compositions Comprising Them and Methods of Their Use
Methods of Treating Rheumatoid Arthritis
Compositions and Methods for Treating Immunological and Inflammatory Diseases and Disorders
Methods of Preparing Imidazole-Based Compounds
Methods of Preparing Imidazole-Based Compounds
Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
Methods and Compounds Useful for the Preparation of Sodium Glucose Co-Transporter 2 Inhibitors
Methods and Compounds Useful for the Preparation of Sodium Glucose Co-Transporter 2 Inhibitors
Process for Preparing 5-Alkyl-7H-Pyrrolo[2,3-D] Pyrimindine-2-Ols
O-Linked Pyrimidin-4-Amine-Based Compounds, Compositions Comprising Them, and Methods of Their Use to Treat Cancer
4-Amino-1H-Pyrimidin-2-One Based Compounds, Compositions Comprising Them and Methods of Their Use
Substituted Pyrrolo[2,3-D]Pyrimidines as Lim Kinase 2 Inhibitors
Aryl Pyridines and Methods of Their Use
Novel Thiazolopyrazoles and Methods of Their Use
Knockout Animals Manifesting Hyperlipidemia
Patent:
7,402,730 →
Application:
11/347,838 →
Solid Forms of (1R,2S,3R)-1-(2-(Isoxazol-3-Yl)-1H-Imidazol-4-Yl)Butane-1,2,3,4-Tetraol and Methods of Their Use
Methods of Preparing Imidazole-Based Bicyclic Compounds
LIMK2 Inhibitors, Compositions Comprising Them, and Methods of Their Use
Monoclonal Antibodies Against ANGPTL4
Monoclonal Antibodies Against ANGPTL4
Monoclonal Antibodies Against ANGPTL3
Monoclonal Antibodies Against ANGPTL3
Solid Forms of (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Methylthio)Tetrahydro-2H-Pyran-3,4,5-Triol and Methods of Their Use
Methods of Treating Diabetes
Solid Forms of 3-(4-(Aminomethyl)-1-(5-Methyl-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Piperidine-4-Carboxamido)Phenyl Dimethylcarbamate
Antibodies That Bind Notum Pectinacetylesterase
Modulators of G Protein-Coupled Receptor 88
Modulators of G Protein-Coupled Receptor 88
Modulators of G Protein-Coupled Receptor 88
Imidazo[1,2-B]Pyridazine-Based Compounds, Compositions Comprising Them, and Methods of Their Use
Pyrazolo[1,5-A]Pyrimidine-Based Compounds, Compositions Comprising Them, and Methods of Their Use
PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
Inhibitors of Sodium Glucose Cotransporter 1
Inhibitors of Sodium Glucose Cotransporter 1
Inhibitors of Sodium Glucose Transporter 1 for Constipation
PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
Inhibitors of Adapter Associated Kinase 1, Compositions Comprising Them, and Methods of Their Use
Crystalline Solid Forms of N-(1-((2-(Dimethylamino)Ethyl)Amino)-2-Methyl-1-Oxopropan-2-Yl)-4-(4-(2-Methyl-5-((2S,3R,4R,5S,6R)-3,4,5-Trihydroxy-6-(Methylthio)Tetrahydro-2H-Pyran-2-Yl)Benzyl)Phenyl)Butanamide and Methods of Their Synthesis
Continuous Process for Preparing the Crystalline Form Ii of Sotagliflozin
Compounds and Methods for Treating Viral Infections
Pyrazolo[1,5]Pyrimidine-Based Compounds and Methods of Their Use to Treat Viral Infections
Methods and Compounds Useful in the Synthesis of an AAK1 Inhibitor
Solid Forms of (S)-1-((2',6-Bis(Difluoromethyl)-[2,4'-Bipyridin]-5-Yl)Oxy)-2,4-Dimethylpentan-2-Amine and Salts Thereof
Antibacterial Agents
Antibacterial Agents
Antibacterial Agents
Substituted Benzamidines as Antibacterial Agents
Aromatic Amides and Uses Thereof
Methods of Reducing the Risk of Cardiovascular Events in Patients with Left Ventricular Hypertrophy
PCT:
PCT/US2024/049710 ↗
Compounds and Methods for Treating Chemotherapy-Induced Pain
PCT:
PCT/US2025/015790 ↗
Methods of Treating Type 1 Diabetes and Kidney Disease
PCT:
PCT/US2024/048524 ↗
Compounds and Methods of Their Use
PCT:
PCT/US2025/015714 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
Assignment of Assignor's Interest
Mar 26, 2018
From: HARRISON, BRYCE ALDEN; KIMBALL, SPENCER DAVID; MABON, ROSS; RAWLINS, DAVID BRENT
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 045350/0355 →
Assignment of Assignor's Interest
Mar 26, 2018
From: GOODWIN, NICOLE C
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 045350/0884 →
Assignment of Assignor's Interest
Mar 26, 2018
From: GOODWIN, NICOLE C
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 045350/0684 →
Assignment of Assignor's Interest
Mar 26, 2018
From: HARRISON, BRYCE ALDEN; KIMBALL, SPENCER DAVID; MABON, ROSS; RAWLINS, DAVID BRENT
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 045350/0424 →
Release of Security Interest
Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
Change of Name
Feb 24, 2022
From: LEXICON GENETICS INCORPORATED
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 059240/0463 →
Security Interest
Mar 17, 2022
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 059432/0709 →
Assignment of Assignor's Interest
Jul 7, 2022
From: BUREL, BRUNO; CEZERAC, JÉROME; DUTHEIL, STÉPHANE; ETIENNE, MARTIAL
To: SANOFI
Reel/Frame 060457/0118 →
Assignment of Assignor's Interest
Jul 22, 2022
From: SANOFI
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 060593/0471 →
Amendment to Previously Filed Security Interest
May 17, 2023
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 063666/0326 →
Assignment of Assignor's Interest
Jun 29, 2023
From: GOPINATHAN, SUMA; TYLE, PRAVEEN; YANG, QI MELISSA
To: LEXICON PHARMACEUTICALS INC.
Reel/Frame 064111/0595 →
Security Interest
Aug 16, 2023
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064608/0846 →
Assignment of Assignor's Interest
Oct 4, 2023
From: CHARITÉ-UNIVERSITÄTSMEDIZIN BERLIN
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 065122/0515 →
Assignment of Assignor's Interest
Mar 27, 2024
From: BANKS, PHILLIP; SAWHNEY, SANGEETA
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 066922/0428 →
Assignment of Assignor's Interest
Nov 22, 2024
From: DAVIES, MICHAEL JOHN
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 069373/0743 →
Assignment of Assignor's Interest
Nov 22, 2024
From: DAVIES, MICHAEL JOHN
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 069374/0279 →
Assignment of Assignor's Interest
Jan 30, 2025
From: WARNER, CHRISTOPHER WILDER
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 070064/0874 →
Assignment of Assignor's Interest
Apr 2, 2025
From: GOPINATHAN, SUMA; WILSON, ALAN GEORGE ERNEST
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 070706/0826 →
Assignment of Assignor's Interest
May 1, 2025
From: MAIN, ALAN JOSEPH
To: LEXICON PHARMACEUTICALS (NEW JERSEY), INC.
Reel/Frame 070995/0477 →
Assignment of Assignor's Interest
May 1, 2025
From: ORTON, DARREN
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 070995/0346 →
Assignment of Assignor's Interest
May 1, 2025
From: LEVY, THOMAS BERNARD; PALLIN, THOMAS DAVID; PASQUA, ADELE ELISA; SAVY, PASCAL PIERRE ALEXANDRE
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 070995/0555 →
Assignment of Assignor's Interest
May 2, 2025
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES
Reel/Frame 071006/0701 →
Assignment of Assignor's Interest
May 2, 2025
From: LEXICON PHARMACEUTICALS (NEW JERSEY), INC.
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 071006/0417 →
Assignment of Assignor's Interest
May 5, 2025
From: CHARLES RIVER LABORATORIES
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 071018/0702 →